Miranda-Nava G, García-Toribio MG

Language: Spanish
References: 22
Page: 98-103
PDF size: 428.12 Kb.

ABSTRACT

Introduction: Marchiafava-Bignami (MB) is a rare disease characterized by the primary degeneration of the callosum mainly associated with chronic consumption of alcohol. However, this condition can be mistaken for many other diseases which cause lesions of the corpus callosum. Even though it has told Carducci was the first in reporting a case of MB in 1898, this disease was originally named in honor of two Italian pathologists in 1903, Ettore Machiafava and Amico Bignami, who described the symptoms of an Italian male with excessive consumption of red wine. The majority of patients are male, aged between 40 to 60 years old, with a history of chronic alcoholism and malnutrition. In these cases morbidity and mortality rates are relatively high. In 2004, there were approximately 250 patients described, 200 of them died, 30 were reported with severe dementia and just 20 patients had a positive outcome.
The treatment for MB is still controversial and shows changing outcomes. Some authors have proposed some benefits following the administration of vitamin B, corticosteroids and amantadine.
Case Report: A 41-year-old male with a history of 15 years of chronic alcohol abuse drinking whisky and rum; presents disorientation, minor psychomotor agitation; during physical examination the patient presents dysarthry and ataxy. The family member of the patient reports that the patient has presented frequent forgetfulness even causing him labor problems. Nuclear magnetic resonance FLAIR images revealing the presence of demyelination of the corpus callosum, such as a little alteration of the white matter of the brain.

REFERENCES

1. Navarro JF, Noriega S. Enfermedad de Marchiafava Bignami. Rev Neurol. 1999; 28: 519-523.

2. Marchiafava E, Bignami A. Sopra una alterazione del corpo calloso osservata in soggeti alcolisti. Riv Pat Nerv Ment. 1903; 8:544-9.

3. Gervith RS, Mendizábal RG. Enfermedad de Marchiafava-Bignami. Arch Neurocien. (Mex) Vol. 13, No. 2: 138-142; 2008.

4. Yongjian C, Lei Z, Xiaoli W, Weiwen Z et al. Marchiafava-Bignami disease with rare etiology: A case report, Experimental and Therapeutic Medicine. 2015; 9: 1515-1517.

5. Samine B, Sirous N, Farrokh ST, Hossein R-D et al. Marchiafava-Bignami and Alcohol Related Acute Polyneuropathy: The Cooccurrence of Two Rare Entities, Case Reports in Neurological Medicine. 2016.

6. Sunil K, Rimiki C, Naveen J, Jatishwor S. Marchiafava - Bignami disease: Review of Imaging Features & Case Report, Journal of Clinical and Diagnostic Research. 2014; Vol-8(8): RD01-RD02

7. Wenz H, Eisele P, Artemis D, Förster A et al. Acute Marchiafava-Bignami Disease with Extensive Diffusion Restriction and Early Recovery: Case Report and Review of the Literature, Journal of Neuroimaging. 2014; Vol 24 No 4.

8. Tekwani PH. Marchiafava-Bignami disease in chronic alcoholic patient. Radiology Case Reports II. (2016); 234-237

9. Caulo M, Briganti C, Notturno F, Committeri G et al. Non-Alcoholic Partially Reversible Marchiafava-Bignami Disease: Review and Relation with Reversible Splenial Lesions A Case Report and Literature Review. The Neuroradiology Journal. 2009; 22: 35-40.

10. 2 Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK et al. Diagnosis and management of Marchiafava- Bignami Disease: A review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry. 2014; 85(2): 168–173.

11. 1 Mestrinelli PE, Marques dos Santos MB, Piasecki L, Cezar JA. Marchiafava-Bignami disease: a rare entity with a poor outcome. Rev Bras Ter Intensiva. 2013; 25(1):68-72.

12. Tavares L, Freua F, Kok F. Chronic stage of Marchiafava –Bignami disease. Images in Neurology. 2015.

13. Namekawa M, Nakamura Y, Nakano I. Cortical Involvement in Marchiafava-Bignami Disease Can Be a Predictor of a Poor Prognosis: A Case Report and Review of the Literature. 2013; Intern Med. 52: 811-813.

14. Augusto L, Figueiredo R, Costa H, Reis C. Marchiafava-Bignami disease as a cause of visual hallucinations. Rev Bras Psiquiatr. 2015; 37:82–83.

15. Yadala S, Luo JJ. Marchiafava-Bignami Disease in a Nonalcoholic Diabetic Patient. Case Reports in Neurological Medicine. 2013.

16. Furukawa K, Maeshima E, Maeshima S, Ichinose M. Multiple symptoms of higher brain dysfunction caused by Marchiafava–Bignami disease in a patient with dermatomyositis. Rheumatol Int. 2011; 31:109–112.

17. Hoshino Y, Ueno Y, Shimura H, Miyamoto N et al. Marchiafava-Bignami disease mimics motor neuron disease: case report. BMC Neurology. 2013; 13:208.

18. Rickert CH, Karger B, Varchmin-Schultheiß K, Brinkmann B, Paulus W. Neglect-associated fatal Marchiafava-Bignami disease in a non-alcoholic woman. Int J Legal Med. 2001; 115: 90–93.

19. Consoli A, Pirritano D, Bosco D, Postorino P et al. Corticosteroid treatment in a patient with Marchiafava–Bignami disease. Neurol Sci. 2014; 35:1143–1145.

20. Kinno R, Yamamoto M, Yamazaki T, Owan Y et al. Cerebral microhemorrhage in Marchiafava– Bignami disease detected by susceptibility-weighted imaging. Neurol Sci. 2013; 34:545–548.

21. Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava-Bignami disease. J Neurol. 2004; 251 : 1050–1059.

22. Clavier E, Thiebot J, Delangre T, Hannequin D et al. Marchiafava-Bignami disease A case studied by CT and MR imaging. Neuroradiology. 1986; 28:376.